Editorial comment: liver transplantation

Curr Opin Organ Transplant. 2009 Jun;14(3):219-20. doi: 10.1097/MOT.0b013e32832c495e.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Alemtuzumab
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm / therapeutic use
  • Antiviral Agents / therapeutic use
  • Graft Survival*
  • Hepatitis B / mortality
  • Hepatitis B / prevention & control
  • Hepatitis B / surgery*
  • Hepatitis C / drug therapy
  • Hepatitis C / mortality
  • Hepatitis C / surgery*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Liver Transplantation / adverse effects*
  • Liver Transplantation / mortality
  • Recurrence
  • Renal Insufficiency / etiology
  • Renal Insufficiency / therapy
  • Time Factors
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Antiviral Agents
  • Immunosuppressive Agents
  • Alemtuzumab